Predictors of Response to Intravitreal Anti-Vascular Endothelial Growth Factor Treatment of Age-Related Macular Degeneration

被引:0
|
作者
Shah, Anjali [1 ]
Williams, Steven [2 ,3 ]
Baumal, Caroline [2 ,3 ]
Rosner, Bernard [4 ]
Duker, Jay S. [2 ,3 ]
Seddon, Johanna [2 ,5 ]
机构
[1] Univ Michigan, Ophthalmol, Ann Arbor, MI 48109 USA
[2] New England Eye Ctr, Boston, MA USA
[3] Tufts Med Ctr, Ophthalmol, Boston, MA USA
[4] Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA
[5] Tufts Med Ctr, Ophthalm Epidemiol & Genet Serv, Boston, MA USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
3788
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Status of Usage of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration
    Cho, Songhee
    Shin, Sang Jin
    Suh, Jae Kyung
    Tchoe, Hajin
    Kang, Min Joo
    Yang, Jangmi
    Jee, Donghyun
    [J]. JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2019, 60 (08): : 758 - 764
  • [22] Disparities in access to anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration
    Finger, Robert P.
    Xie, Jing
    Fotis, Kathy
    Parikh, Sumit
    Cummins, Rob
    Mitchell, Paul
    Guymer, Robyn H.
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 (02): : 143 - 151
  • [23] Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration
    Finger, Robert P.
    Puth, Marie-Therese
    Schmid, Matthias
    Barthelmes, Daniel
    Guymer, Robyn H.
    Gillies, Mark
    [J]. JAMA OPHTHALMOLOGY, 2020, 138 (12) : 1234 - 1240
  • [24] When Should Anti-Vascular Endothelial Growth Factor Treatment Be Stopped in Age-Related Macular Degeneration?
    Gaudric, Alain
    Cohen, Salomon Y.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 149 (01) : 4 - 6
  • [25] Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment
    Mantel, Irmela
    Borgo, Angelica
    Guidotti, Jacopo
    Forestier, Edwige
    Kirsch, Olga
    Derradji, Yasmine
    Waridel, Patrice
    Burdet, Frederic
    Mehl, Florence
    Schweizer, Claude
    Roduit, Raphael
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [26] Topical dorzolamide-timolol with intravitreal anti-vascular endothelial growth factor for neovascular age-related macular degeneration
    Sridhar, Jayanth
    Hsu, Jason
    Shahlaee, Abtin
    Garg, Sunir
    Spirn, Marc
    Fineman, Mitchell
    Vander, James
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [27] Smoking and short-term response to intravitreal anti-Vascular Endothelial Growth Factor injections in neovascular age-related macular degeneration
    Caspers, S.
    Abramowicz, S.
    Pasteels, B.
    Postelmans, L.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2024, 47 (01):
  • [28] Intravitreal aflibercept efficacy in neovascular age-related macular degeneration with suboptimal response to anti-vascular endothelial growth factor-A therapy
    Mones, Jordi
    Biarnes, Marc
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (05) : 1082 - 1090
  • [29] Safety of Anti-Vascular Endothelial Growth Factor (anti-VEGF) Intravitreal Injections for the Treatment of Patients with Age-Related Macular Degeneration (AMD)
    Moura, Cristiano S.
    Machado, Marina A. A.
    Behlouli, Hassan
    Campbell, Robert
    Bernatsky, Sasha
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 61 - 62
  • [30] Anti-vascular endothelial growth factor in age-related macular degeneration: Puzzle or a silent beginning!
    Natarajan, Sundaram
    [J]. INDIAN JOURNAL OF OPHTHALMOLOGY, 2013, 61 (09) : 475 - 478